Stay updated on Evinacumab in Pediatric Homozygous FH Clinical Trial
Sign up to get notified when there's something new on the Evinacumab in Pediatric Homozygous FH Clinical Trial page.

Latest updates to the Evinacumab in Pediatric Homozygous FH Clinical Trial page
- Check4 days agoChange DetectedA new Revision: v3.3.3 is added and the HHS Vulnerability Disclosure entry is removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe Record History shows a new revision entry (v3.3.2) and removal of an older revision (v3.2.0), indicating an update to the page's version history.SummaryDifference0.1%

- Check40 days agoChange DetectedDeleted the site-wide notice about government funding and NIH operating status.SummaryDifference0.7%

- Check54 days agoChange DetectedThe new version updates the study status and recruitment status. Contacts/Locations details were revised to reflect the current state of the trial.SummaryDifference0.1%

- Check83 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference11%

- Check90 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.3%

Stay in the know with updates to Evinacumab in Pediatric Homozygous FH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evinacumab in Pediatric Homozygous FH Clinical Trial page.